New Delhi:In a bid to bolster the fight against future pandemics, India's top scientific advisor Prof Ajay Kumar Sood has urged G20 countries to collaborate in developing vaccine platforms by cooperating with each other in the pre-competitive research and development phase. In a video interview with PTI, Sood, who will chair the Chief Scientific Advisors' Roundtable (CSAR) of G20 countries next week, said India will also present its traditional systems of medicine and seek to harness the knowledge of indigenous communities of different countries.
Making a strong pitch for collaboration among G20 nations in drug development, Sood, the principal scientific advisor to the government, said there is enormous scope for cooperation in the pre-competitive research and development space. "Once it reaches a certain level of maturity, of course different countries will have their take. But pre-competitive R&D (research and development) space is what we think should be something where we should work," he said.
Sood identified emerging technologies for environmental surveillance as another area for cooperation. "This is something which has to be done by all countries. A lot of it is happening but there are many other countries which will need a helping hand. So, we should be ready to take everyone along," he said. Pre-competitive collaboration involves two or more companies operating within the same industry coming together to address a shared problem or pain point that doesn't impact direct business competition or contribute to unfair advantage.
"When there is a pandemic, you cannot live in isolation. We have seen it in Covid, all countries will have to fight it together and it has to be eradicated or controlled at all places. If it does not, then it will linger on and that is what you are seeing for Covid," Sood said. He said the CSAR meeting in Uttarakhand's Ramnagar from March 28-30 will also focus on harnessing the benefits of traditional knowledge in healthcare.